Global HPV Therapeutic Vaccines Market Research Report 2021

SKU ID :QYR-19350547 | Published Date: 14-Oct-2021 | No. of pages: 101
1 HPV Therapeutic Vaccines Market Overview 1.1 Product Overview and Scope of HPV Therapeutic Vaccines 1.2 HPV Therapeutic Vaccines Segment by Type 1.2.1 Global HPV Therapeutic Vaccines Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Bivalent HPV vaccine 1.2.3 Quadrivalent HPV vaccine 1.3 HPV Therapeutic Vaccines Segment by Application 1.3.1 Global HPV Therapeutic Vaccines Sales Comparison by Application: (2021-2027) 1.3.2 Man 1.3.3 Woman 1.4 Global HPV Therapeutic Vaccines Market Size Estimates and Forecasts 1.4.1 Global HPV Therapeutic Vaccines Revenue 2016-2027 1.4.2 Global HPV Therapeutic Vaccines Sales 2016-2027 1.4.3 HPV Therapeutic Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027 2 HPV Therapeutic Vaccines Market Competition by Manufacturers 2.1 Global HPV Therapeutic Vaccines Sales Market Share by Manufacturers (2016-2021) 2.2 Global HPV Therapeutic Vaccines Revenue Market Share by Manufacturers (2016-2021) 2.3 Global HPV Therapeutic Vaccines Average Price by Manufacturers (2016-2021) 2.4 Manufacturers HPV Therapeutic Vaccines Manufacturing Sites, Area Served, Product Type 2.5 HPV Therapeutic Vaccines Market Competitive Situation and Trends 2.5.1 HPV Therapeutic Vaccines Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest HPV Therapeutic Vaccines Players Market Share by Revenue 2.5.3 Global HPV Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 HPV Therapeutic Vaccines Retrospective Market Scenario by Region 3.1 Global HPV Therapeutic Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global HPV Therapeutic Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America HPV Therapeutic Vaccines Market Facts & Figures by Country 3.3.1 North America HPV Therapeutic Vaccines Sales by Country 3.3.2 North America HPV Therapeutic Vaccines Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe HPV Therapeutic Vaccines Market Facts & Figures by Country 3.4.1 Europe HPV Therapeutic Vaccines Sales by Country 3.4.2 Europe HPV Therapeutic Vaccines Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific HPV Therapeutic Vaccines Market Facts & Figures by Region 3.5.1 Asia Pacific HPV Therapeutic Vaccines Sales by Region 3.5.2 Asia Pacific HPV Therapeutic Vaccines Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America HPV Therapeutic Vaccines Market Facts & Figures by Country 3.6.1 Latin America HPV Therapeutic Vaccines Sales by Country 3.6.2 Latin America HPV Therapeutic Vaccines Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa HPV Therapeutic Vaccines Market Facts & Figures by Country 3.7.1 Middle East and Africa HPV Therapeutic Vaccines Sales by Country 3.7.2 Middle East and Africa HPV Therapeutic Vaccines Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global HPV Therapeutic Vaccines Historic Market Analysis by Type 4.1 Global HPV Therapeutic Vaccines Sales Market Share by Type (2016-2021) 4.2 Global HPV Therapeutic Vaccines Revenue Market Share by Type (2016-2021) 4.3 Global HPV Therapeutic Vaccines Price by Type (2016-2021) 5 Global HPV Therapeutic Vaccines Historic Market Analysis by Application 5.1 Global HPV Therapeutic Vaccines Sales Market Share by Application (2016-2021) 5.2 Global HPV Therapeutic Vaccines Revenue Market Share by Application (2016-2021) 5.3 Global HPV Therapeutic Vaccines Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Merck & Co., Inc 6.1.1 Merck & Co., Inc Corporation Information 6.1.2 Merck & Co., Inc Description and Business Overview 6.1.3 Merck & Co., Inc HPV Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Merck & Co., Inc HPV Therapeutic Vaccines Product Portfolio 6.1.5 Merck & Co., Inc Recent Developments/Updates 6.2 GlaxoSmithKline plc 6.2.1 GlaxoSmithKline plc Corporation Information 6.2.2 GlaxoSmithKline plc Description and Business Overview 6.2.3 GlaxoSmithKline plc HPV Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.2.4 GlaxoSmithKline plc HPV Therapeutic Vaccines Product Portfolio 6.2.5 GlaxoSmithKline plc Recent Developments/Updates 6.3 Shanghai Bovax Biotechnology Co., Ltd. 6.3.1 Shanghai Bovax Biotechnology Co., Ltd. Corporation Information 6.3.2 Shanghai Bovax Biotechnology Co., Ltd. Description and Business Overview 6.3.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Product Portfolio 6.3.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Developments/Updates 6.4 Profectus BioSciences, Inc. 6.4.1 Profectus BioSciences, Inc. Corporation Information 6.4.2 Profectus BioSciences, Inc. Description and Business Overview 6.4.3 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Product Portfolio 6.4.5 Profectus BioSciences, Inc. Recent Developments/Updates 6.5 2A Pharma AB 6.5.1 2A Pharma AB Corporation Information 6.5.2 2A Pharma AB Description and Business Overview 6.5.3 2A Pharma AB HPV Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.5.4 2A Pharma AB HPV Therapeutic Vaccines Product Portfolio 6.5.5 2A Pharma AB Recent Developments/Updates 6.6 ISA Pharmaceuticals 6.6.1 ISA Pharmaceuticals Corporation Information 6.6.2 ISA Pharmaceuticals Description and Business Overview 6.6.3 ISA Pharmaceuticals HPV Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.6.4 ISA Pharmaceuticals HPV Therapeutic Vaccines Product Portfolio 6.6.5 ISA Pharmaceuticals Recent Developments/Updates 7 HPV Therapeutic Vaccines Manufacturing Cost Analysis 7.1 HPV Therapeutic Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of HPV Therapeutic Vaccines 7.4 HPV Therapeutic Vaccines Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 HPV Therapeutic Vaccines Distributors List 8.3 HPV Therapeutic Vaccines Customers 9 HPV Therapeutic Vaccines Market Dynamics 9.1 HPV Therapeutic Vaccines Industry Trends 9.2 HPV Therapeutic Vaccines Growth Drivers 9.3 HPV Therapeutic Vaccines Market Challenges 9.4 HPV Therapeutic Vaccines Market Restraints 10 Global Market Forecast 10.1 HPV Therapeutic Vaccines Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of HPV Therapeutic Vaccines by Type (2022-2027) 10.1.2 Global Forecasted Revenue of HPV Therapeutic Vaccines by Type (2022-2027) 10.2 HPV Therapeutic Vaccines Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of HPV Therapeutic Vaccines by Application (2022-2027) 10.2.2 Global Forecasted Revenue of HPV Therapeutic Vaccines by Application (2022-2027) 10.3 HPV Therapeutic Vaccines Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of HPV Therapeutic Vaccines by Region (2022-2027) 10.3.2 Global Forecasted Revenue of HPV Therapeutic Vaccines by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global HPV Therapeutic Vaccines Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global HPV Therapeutic Vaccines Sales (K Units) Comparison by Application (2021-2027) Table 3. Global HPV Therapeutic Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers HPV Therapeutic Vaccines Covered in This Study Table 5. Global HPV Therapeutic Vaccines Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global HPV Therapeutic Vaccines Sales Market Share by Manufacturers (2016-2021) Table 7. Global HPV Therapeutic Vaccines Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global HPV Therapeutic Vaccines Revenue Share by Manufacturers (2016-2021) Table 9. Global Market HPV Therapeutic Vaccines Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers HPV Therapeutic Vaccines Manufacturing Sites and Area Served Table 11. Manufacturers HPV Therapeutic Vaccines Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global HPV Therapeutic Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HPV Therapeutic Vaccines as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global HPV Therapeutic Vaccines Sales by Region (2016-2021) & (K Units) Table 16. Global HPV Therapeutic Vaccines Sales Market Share by Region (2016-2021) Table 17. Global HPV Therapeutic Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 18. North America HPV Therapeutic Vaccines Sales by Country (2016-2021) & (K Units) Table 19. North America HPV Therapeutic Vaccines Sales Market Share by Country (2016-2021) Table 20. North America HPV Therapeutic Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 21. North America HPV Therapeutic Vaccines Revenue Market Share by Country (2016-2021) Table 22. Europe HPV Therapeutic Vaccines Sales by Country (2016-2021) & (K Units) Table 23. Europe HPV Therapeutic Vaccines Sales Market Share by Country (2016-2021) Table 24. Europe HPV Therapeutic Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe HPV Therapeutic Vaccines Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific HPV Therapeutic Vaccines Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific HPV Therapeutic Vaccines Sales Market Share by Region (2016-2021) Table 28. Asia Pacific HPV Therapeutic Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific HPV Therapeutic Vaccines Revenue Market Share by Region (2016-2021) Table 30. Latin America HPV Therapeutic Vaccines Sales by Country (2016-2021) & (K Units) Table 31. Latin America HPV Therapeutic Vaccines Sales Market Share by Country (2016-2021) Table 32. Latin America HPV Therapeutic Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America HPV Therapeutic Vaccines Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa HPV Therapeutic Vaccines Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa HPV Therapeutic Vaccines Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa HPV Therapeutic Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa HPV Therapeutic Vaccines Revenue Market Share by Country (2016-2021) Table 38. Global HPV Therapeutic Vaccines Sales (K Units) by Type (2016-2021) Table 39. Global HPV Therapeutic Vaccines Sales Market Share by Type (2016-2021) Table 40. Global HPV Therapeutic Vaccines Revenue (Million US$) by Type (2016-2021) Table 41. Global HPV Therapeutic Vaccines Revenue Share by Type (2016-2021) Table 42. Global HPV Therapeutic Vaccines Price (USD/Unit) by Type (2016-2021) Table 43. Global HPV Therapeutic Vaccines Sales (K Units) by Application (2016-2021) Table 44. Global HPV Therapeutic Vaccines Sales Market Share by Application (2016-2021) Table 45. Global HPV Therapeutic Vaccines Revenue (Million US$) by Application (2016-2021) Table 46. Global HPV Therapeutic Vaccines Revenue Share by Application (2016-2021) Table 47. Global HPV Therapeutic Vaccines Price (USD/Unit) by Application (2016-2021) Table 48. Merck & Co., Inc Corporation Information Table 49. Merck & Co., Inc Description and Business Overview Table 50. Merck & Co., Inc HPV Therapeutic Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Merck & Co., Inc HPV Therapeutic Vaccines Product Table 52. Merck & Co., Inc Recent Developments/Updates Table 53. GlaxoSmithKline plc Corporation Information Table 54. GlaxoSmithKline plc Description and Business Overview Table 55. GlaxoSmithKline plc HPV Therapeutic Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. GlaxoSmithKline plc HPV Therapeutic Vaccines Product Table 57. GlaxoSmithKline plc Recent Developments/Updates Table 58. Shanghai Bovax Biotechnology Co., Ltd. Corporation Information Table 59. Shanghai Bovax Biotechnology Co., Ltd. Description and Business Overview Table 60. Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Product Table 62. Shanghai Bovax Biotechnology Co., Ltd. Recent Developments/Updates Table 63. Profectus BioSciences, Inc. Corporation Information Table 64. Profectus BioSciences, Inc. Description and Business Overview Table 65. Profectus BioSciences, Inc. HPV Therapeutic Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Profectus BioSciences, Inc. HPV Therapeutic Vaccines Product Table 67. Profectus BioSciences, Inc. Recent Developments/Updates Table 68. 2A Pharma AB Corporation Information Table 69. 2A Pharma AB Description and Business Overview Table 70. 2A Pharma AB HPV Therapeutic Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. 2A Pharma AB HPV Therapeutic Vaccines Product Table 72. 2A Pharma AB Recent Developments/Updates Table 73. ISA Pharmaceuticals Corporation Information Table 74. ISA Pharmaceuticals Description and Business Overview Table 75. ISA Pharmaceuticals HPV Therapeutic Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. ISA Pharmaceuticals HPV Therapeutic Vaccines Product Table 77. ISA Pharmaceuticals Recent Developments/Updates Table 78. Production Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. HPV Therapeutic Vaccines Distributors List Table 81. HPV Therapeutic Vaccines Customers List Table 82. HPV Therapeutic Vaccines Market Trends Table 83. HPV Therapeutic Vaccines Growth Drivers Table 84. HPV Therapeutic Vaccines Market Challenges Table 85. HPV Therapeutic Vaccines Market Restraints Table 86. Global HPV Therapeutic Vaccines Sales Forecast by Type (2022-2027) & (K Units) Table 87. Global HPV Therapeutic Vaccines Sales Market Share Forecast by Type (2022-2027) Table 88. Global HPV Therapeutic Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million) Table 89. Global HPV Therapeutic Vaccines Revenue Market Share Forecast by Type (2022-2027) Table 90. Global HPV Therapeutic Vaccines Sales Forecast by Application (2022-2027) & (K Units) Table 91. Global HPV Therapeutic Vaccines Sales Market Share Forecast by Application (2022-2027) Table 92. Global HPV Therapeutic Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million) Table 93. Global HPV Therapeutic Vaccines Revenue Market Share Forecast by Application (2022-2027) Table 94. Global HPV Therapeutic Vaccines Sales Forecast by Region (2022-2027) & (K Units) Table 95. Global HPV Therapeutic Vaccines Sales Market Share Forecast by Region (2022-2027) Table 96. Global HPV Therapeutic Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million) Table 97. Global HPV Therapeutic Vaccines Revenue Market Share Forecast by Region (2022-2027) Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of HPV Therapeutic Vaccines Figure 2. Global HPV Therapeutic Vaccines Market Share by Type in 2020 & 2027 Figure 3. Bivalent HPV vaccine Product Picture Figure 4. Quadrivalent HPV vaccine Product Picture Figure 5. Global HPV Therapeutic Vaccines Market Share by Application in 2020 & 2027 Figure 6. Man Figure 7. Woman Figure 8. Global HPV Therapeutic Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global HPV Therapeutic Vaccines Market Size 2016-2027 (US$ Million) Figure 10. Global HPV Therapeutic Vaccines Sales 2016-2027 (K Units) Figure 11. Global HPV Therapeutic Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. HPV Therapeutic Vaccines Sales Share by Manufacturers in 2020 Figure 13. Global HPV Therapeutic Vaccines Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest HPV Therapeutic Vaccines Players: Market Share by Revenue in 2020 Figure 15. HPV Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global HPV Therapeutic Vaccines Sales Market Share by Region (2016-2021) Figure 17. Global HPV Therapeutic Vaccines Sales Market Share by Region in 2020 Figure 18. Global HPV Therapeutic Vaccines Revenue Market Share by Region (2016-2021) Figure 19. Global HPV Therapeutic Vaccines Revenue Market Share by Region in 2020 Figure 20. U.S. HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Canada HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Germany HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. France HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. U.K. HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Italy HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Russia HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. China HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Japan HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. South Korea HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. India HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Australia HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Taiwan HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Indonesia HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Thailand HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Malaysia HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Philippines HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Vietnam HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. U.A.E HPV Therapeutic Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of HPV Therapeutic Vaccines by Type (2016-2021) Figure 45. Sales Market Share of HPV Therapeutic Vaccines by Application (2016-2021) Figure 46. Sales Market Share of HPV Therapeutic Vaccines by Application in 2020 Figure 47. Revenue Share of HPV Therapeutic Vaccines by Application (2016-2021) Figure 48. Revenue Share of HPV Therapeutic Vaccines by Application in 2020 Figure 49. Manufacturing Cost Structure of HPV Therapeutic Vaccines Figure 50. Manufacturing Process Analysis of HPV Therapeutic Vaccines Figure 51. HPV Therapeutic Vaccines Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed
Merck & Co., Inc GlaxoSmithKline plc Shanghai Bovax Biotechnology Co., Ltd. Profectus BioSciences, Inc. 2A Pharma AB ISA Pharmaceuticals
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients